APA (7th ed.) Citation

Xilin Hu, Hanlin Xu, Qianwen Xue, Ruran Wen, Wenjie Jiao, & Kaihua Tian. (2021). The role of ERBB4 mutations in the prognosis of advanced non-small cell lung cancer treated with immune checkpoint inhibitors. BMC.

Chicago Style (17th ed.) Citation

Xilin Hu, Hanlin Xu, Qianwen Xue, Ruran Wen, Wenjie Jiao, and Kaihua Tian. The Role of ERBB4 Mutations in the Prognosis of Advanced Non-small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors. BMC, 2021.

MLA (9th ed.) Citation

Xilin Hu, et al. The Role of ERBB4 Mutations in the Prognosis of Advanced Non-small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors. BMC, 2021.